Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | BLVRB | P30043 | 2/20 | 0.68 |
| ▸ | PDE4A | P27815 | 1/20 | 0.68 |
| ▸ | KDR | P35968 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | APP | P05067 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.62 |
| ▸ | RELA | Q04206 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4705233 | 0.88 | MEN1 (0.72) | MEN1KMT2ABLVRBPDE4AKDR | |
| SCHEMBL29723285 | 0.87 | MEN1 (0.70) | MEN1KMT2ABLVRBPDE4AKDR | |
| SCHEMBL8109249 | 0.85 | MEN1 (0.68) | MEN1KMT2ABLVRBPDE4AKDR | |
| SCHEMBL30076649 | 0.82 | KDM4C (0.62) | MEN1KMT2ATDP1MAPTSMN1; SMN2 | |
| SCHEMBL170522 | 0.82 | KDM4C (0.62) | MEN1KMT2ATDP1MAPTSMN1; SMN2 | |
| Olsalazine SCHEMBL29378994 | 0.82 | MEN1 (1.00) | MEN1KMT2ABLVRBPDE4AKDR | |
| Olsalazine SCHEMBL29385751 | 0.82 | MEN1 (1.00) | MEN1KMT2ABLVRBPDE4AKDR | |
| Olsalazine SCHEMBL25118 | 0.82 | MEN1 (1.00) | MEN1KMT2ABLVRBPDE4AKDR | |
| Olsalazine SCHEMBL25119 | 0.82 | MEN1 (1.00) | MEN1KMT2ABLVRBPDE4AKDR | |
| Olsalazine SCHEMBL29861404 | 0.82 | MEN1 (1.00) | MEN1KMT2ABLVRBPDE4AKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210115489-A1 | NOVEL MEDIATOR | KIKKOMAN CORPORATION (JP) | 2021-04-22 | — | — | US | disclosed |
| EP-3780207-A1 | NOVEL MEDIATOR | Kikkoman Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115489-A1 | NOVEL MEDIATOR | MPO, EPX, LPO | MEN1 2351/4885KMT2A 3104/4885BLVRB 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.